(Date:5/21/2008)...y 21 /PRNewswire-FirstCall/ -- Aflac Incorporated,...presentation at the Sanford,C. Bernstein & Co., LL...nce,2008., President and Chief Financial Officer ...ted, and he is scheduled to make a presentation on...orated presentation, Mr.,Cloninger will discuss th...
(Date:5/21/2008)...d SILVER SPRING, Md., May 21 /PRNewswire-USNewswir... (ADAA),( http://www.adaa.org ) and The HealthCent... announced that ADAA will join,HealthCentral,s gro...and,health experts dedicated to helping people suf... advice and support they need to cope with the,con...
(Date:5/21/2008)...s 1st quarter profit, enhanced operations and new ...ELES, May 21 /PRNewswire-FirstCall/ -- InstaCare C...butor of at-home testing diagnostics,for the chron...eveloper of,patent-pending technologies for e-heal...s for the first quarter period-ended March 31, 200...
(Date:5/21/2008)... Adverse Events in TORCH Showed Frequency Highest ...ONTO and RESEARCH TRIANGLE PARK, N.C., May 21 /PRN...500/50 (fluticasone propionate and,salmeterol inha...er of,cardiovascular adverse events compared to ot...from the TOwards a Revolution in COPD Health,(TORC...
Breaking Medicine News(10 mins):Health News:Aflac Incorporated to Present at the Sanford C. Bernstein & Co., LLC Twenty-Fourth Annual Strategic Decisions Conference 2008 2Health News:The Anxiety Disorders Association of America and The HealthCentral Network Form Alliance to Develop New Online Resources for Anxiety Disorders 2Health News:The Anxiety Disorders Association of America and The HealthCentral Network Form Alliance to Develop New Online Resources for Anxiety Disorders 3Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 2Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 3Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 4Health News:InstaCare Corp. in Turnaround Reports 258% Revenues Increase in 1Q 2008 5Health News:Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50 2Health News:Three-Year COPD Study Found No Increase in Cardiac Events With Advair(R) 500/50 3(Date:5/20/2008)... SEATTLE, May 20 /- Ome...patient enrollment for the Phase 1 study of,OMS201...oduct candidate,for use during urological surgery...roscopic removal of stones with a maximum diameter...r ureter will be enrolled in the,study., "Advanci...
(Date:5/20/2008)... - Study shows significantly improved bronchodil...th combination therapy -, NAPA, Calif., May 20 /P...a demonstrating that patients with Chronic Obstruc... and chronic bronchitis, experienced markedly,impr...ted with a,combination of nebulized formoterol fum...
(Date:5/20/2008)... A Separate Retrospective Analysis of US Employer...Factor Therapies on Absenteeism Among Employees wi...e, SAN DIEGO, May 20 /- Data from a ...ls (ACT 1 and ACT 2) showed that at week 8,more t...rely active,ulcerative colitis (UC) receiving REMI...
(Date:5/20/2008)... Data Presented at the 2008 International Conf...Thoracic Society, TORONTO, May 20 /PRNewswire-Fir...ios Almirall, S.A. today presented results from fo...ty of aclidinium bromide, an,investigational treat...PD).,Data from four preclinical studies further de...
Breaking Medicine Technology:Omeros Announces Initiation of Patient Enrollment in OMS201 Phase 1 Study 2Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients 2Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients 3Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients 4Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients 5Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients 6Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD Patients 7New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 2New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 3New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 4New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 5New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 6New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 7New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease 8Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 2Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 3Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 4Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD 5Kristin Chenoweth to Perform Benefit Concert for 3 Angels Memorial Fund titled Kristin Chenoweth This Ones Personal 3A A Concert to Stop ACD 16531 1Kristin Chenoweth to Perform Benefit Concert for 3 Angels Memorial Fund titled Kristin Chenoweth This Ones Personal 3A A Concert to Stop ACD 16531 2Kristin Chenoweth to Perform Benefit Concert for 3 Angels Memorial Fund titled Kristin Chenoweth This Ones Personal 3A A Concert to Stop ACD 16531 3Amnis Announces Release of Powerful New Image Data Analysis Software 4526 1Amnis Announces Release of Powerful New Image Data Analysis Software 4526 2Monell scientist Mark Friedman awarded Guggenheim Fellowship to study diet and obesity 2850 1Monell scientist Mark Friedman awarded Guggenheim Fellowship to study diet and obesity 2850 2Gel Enables Severed Spinal Cord Fibers to Regrow 16522 1Gel Enables Severed Spinal Cord Fibers to Regrow 16522 2..., 2007--A cervical cancer vaccine has shown 90%,ef...ncerous lesions,associated with the human papillom...de authors of an Article published early Online,an...16 and 18 account for 70% or more,cases of cervica...ic HPV types which can contribute to cervical canc...
...ceed with Development Program for Oral Compounds,t...BUSINESS WIRE)--July 2, 2007--Alkermes, Inc.,(Nasd...ults from a,clinical trial of ALKS 29 in alcohol d...pany plans to move forward with its,development pr...,dependence. ALKS 29 is a combination of two agent...
Other Medicine Technology:Vaccine Can Prevent Cervical Cancer and Precancerous Lesions 2Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 2Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 3Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 4Unique product designed for LASIK surgery and other types of refractive surgery. Designed to irrigate the corneal interface and/or stromal bed. Flattened tip provides easy insertion under the flap an
Unique product designed for LASIK surgery and other types of refractive surgery. Designed to irrigate the corneal interface and/or stromal bed. Flattened tip provides easy insertion under the flap an
For injecting viscoelastic to all meridians of the anterior chamber and to coat intraocular lenses. 20G x 7.8in (.90 x 22mm).
For administering anesthetic agents into the posterior sub-Tenon's space 20G x 1in (.90 x 25mm)
Medicine Products: